Certificate number:RU.77.99.11.003.Е.010525.11.14
Date of registration and renewal:11.11.2014
Dosage form: & nbspTablets No. 1 with a mass of 0.5 g ± 0.05 g, tablets No. 2 with a mass of 0.65 g ± 0.065, tablets No. 3 with a mass of 0.6 g ± 0.06
Classification "Composition" & nbsp BAD - vitamin and mineral complexes
Composition: & nbspThe composition of the tablet number 1: ascorbic acid, iron sulfate, retinol acetate, copper citrate, vitamin B1, B9.

Tablet composition No. 2: magnesium citrate, ascorbic acid, vitamin E, PP, zinc oxide, sodium selenite, retinol acetate, vitamin B6, B2, potassium iodate.

Composition of tablet number 3: calcium carbonate, cholecalciferol, vitamin B5, B12, B9.

Excipients: lactose, MCC, calcium / magnesium stearate, aerosil.
Scope: & nbspFor sale to the population through the pharmacy network and specialized stores, the trade network departments as a biologically active food additive (APPENDIX) - an additional source of vitamins A, E, D, C, B1, B2, B6, B12, PP, calcium D-pantothenate vitamin B5), folic acid (vitamin B9), minerals: zinc, iron, copper, iodine, selenium, containing calcium and magnesium.
Suggested Usage: & nbspChildren 7-14 years and adolescents 14-18 years with 1 tablet of each type (№1, №2, №3) per day with meals (breakfast, lunch and dinner in any order). If the recommended intake schedule is broken, you can resume taking any tablet. The interval between doses is 4-6 hours. Duration of admission is 1 month.
Contraindications:Individual intolerance of components, hyperfunction of the thyroid gland. Before use, consult a physician. Persons with thyroid disease need consultation of an endocrinologist.
Shelf life:2 years.
Storage conditions:Store in a dry place inaccessible to children, at a temperature not exceeding 25 ° C.
Research protocols:In exchange for the certificate of state registration No.RU.77.99.11.003.Е.013606.09.12. from 07.09.2012, the expert conclusion of the FBU of the Federal Target Program and the Federal Service for Consumer Rights Protection No. 10-2FTS / 3286 of 08/08/2012.
Recipient:Bitra (Biotechnological development), LLCBitra (Biotechnological development), LLC Russia
Information update date: & nbsp06.05.2016
Instructions
Up